Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.38 is 33% below its 5-year average of 3.56, near the low end of its 5-year range (1.81–9.08).
As of the fiscal period ended Tuesday, June 30, 2026. 15.51% below its 12-month average of 2.82.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.38.
QUICK RATIO (ACID-TEST)
2.38
QUICK RATIO (ACID-TEST) AVG TTM
2.82
QUICK RATIO (ACID-TEST) AVG 3Y
3.09
QUICK RATIO (ACID-TEST) AVG 5Y
3.56
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-15.51%
CURRENT VS 3Y AVG
-22.96%
CURRENT VS 5Y AVG
-32.94%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-28.84%
vs the sector median at left
TELA Bio, Inc.
Market Cap
$49.44M
Quick Ratio (Acid-Test)
2.38
TTM Avg
2.82
3Y Avg
3.09
5Y Avg
3.56
Market Cap
$49.06M
Quick Ratio (Acid-Test)
4.44
TTM Avg
7.28
3Y Avg
7.49
5Y Avg
6.53
Market Cap
$48.76M
Quick Ratio (Acid-Test)
17.82
TTM Avg
12.77
3Y Avg
7.97
5Y Avg
9.78
Market Cap
$49.47M
Quick Ratio (Acid-Test)
1.84
TTM Avg
1.45
3Y Avg
1.28
5Y Avg
1.17
Market Cap
$49.58M
Quick Ratio (Acid-Test)
4.04
TTM Avg
3.34
3Y Avg
3.69
5Y Avg
8.08
Market Cap
$49.02M
Quick Ratio (Acid-Test)
0.96
TTM Avg
1.17
3Y Avg
2.45
5Y Avg
4.99
Market Cap
$50.16M
Quick Ratio (Acid-Test)
3.89
TTM Avg
3.98
3Y Avg
6.90
5Y Avg
10.09
Market Cap
$50.37M
Quick Ratio (Acid-Test)
1.61
TTM Avg
0.71
3Y Avg
0.60
5Y Avg
0.61
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TELA Bio, Inc. (TELA) | $49.44M | 2.38 | 2.82 | 3.09 | 3.56 |
| Sensus Healthcare, Inc. (SRTS)vs › | $49.06M | 4.44 | 7.28 | 7.49 | 6.53 |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | 17.82 | 12.77 | 7.97 | 9.78 |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.47M | 1.84 | 1.45 | 1.28 | 1.17 |
| INmune Bio, Inc. (INMB)vs › | $49.58M | 4.04 | 3.34 | 3.69 | 8.08 |
| Apollomics, Inc. (APLM)vs › | $49.02M | 0.96 | 1.17 | 2.45 | 4.99 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $50.16M | 3.89 | 3.98 | 6.90 | 10.09 |
| Clene Inc. (CLNN)vs › | $50.60M | 3.07 | 1.20 | 1.50 | 3.41 |
| Envoy Medical, Inc. (COCH)vs › | $50.37M | 1.61 | 0.71 | 0.60 | 0.61 |
| Lite Strategy, Inc. (LITS)vs › | $47.81M | 5.74 | 9.62 | 7.35 | 7.40 |
Quick Ratio
2.38
Excludes inventory
Current Ratio
2.99
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.38 |
| 2026-03-31 | 2.92 |
| 2025-12-31 | 3.59 |
| 2025-09-30 | 2.62 |
| 2025-06-30 | 2.59 |
| 2025-03-31 | 3.40 |
| 2024-12-31 | 4.19 |
| 2024-09-30 | 1.81 |
| 2024-06-30 | 2.52 |
| 2024-03-31 | 3.23 |
| 2023-12-31 | 3.45 |
| 2023-09-30 | 4.43 |
| 2023-06-30 | 5.75 |
| 2023-03-31 | 2.67 |
| 2022-12-31 | 4.08 |
| 2022-09-30 | 4.06 |
| 2022-06-30 | 2.96 |
| 2022-03-31 | 3.26 |
| 2021-12-31 | 4.86 |
| 2021-09-30 | 6.32 |
| 2021-06-30 | 9.08 |
| 2021-03-31 | 12.51 |
| 2020-12-31 | 12.01 |
| 2020-09-30 | 15.90 |
| 2020-06-30 | 24.71 |
| 2020-03-31 | 11.94 |
| 2019-12-31 | 8.90 |
| 2019-09-30 | 2.12 |
| 2019-06-30 | 2.67 |
| 2019-03-31 | 0.00 |
| 2018-12-31 | 1.98 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
